Article, Scientific Insights: Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease; A Meta-analysis and matching-adjusted indirect comparison